AIDS 2018: Accelerating the development and uptake of the most needed drug formulations for children
27 Aug, 2018
The 22nd International AIDS Conference in Amsterdam, The Netherlands 23 - 27 July 2018 hosted the session "Accelerating the development and uptake of the most needed drug formulations for children".
Read MoreWHO: interim guidance policy brief publication
08 Aug, 2018
The World Health Organisation has published updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV.
Read MorePED-MERMAIDS has reached 50% of enrollment target!
03 Aug, 2018
We are delighted to announce that the study PED-MERMAIDS has surpassed 50% of the enrollment target of 1,000 patients. This is a great achievement and we extend our thanks to…
Read MoreWHO Toolkit for research and development of paediatric antiretroviral drugs and formulations
23 Jul, 2018
Martina Penazzato (MD, DTMH, MSc, PhD) has recently presented the WHO toolkit for research and development of paediatric antiretroviral drugs and formulations at the 22nd International AIDS Conference, Amsterdam, the…
Read MoreThird issue of the ZIKA Consortia Newsletter
10 Jul, 2018
In this third issue of the joint EU funded ZIKA Consortia newsletter, you can read about the recent International ZIKA symposium, held in Marseille, France, where ZIKAction presented the work…
Read MoreAn EPIICAL paper has been accepted for publication in the Journal of Acquired Immune Deficiency Syndromes (JAIDS)
02 Jul, 2018
In the paper Early and highly suppressive ART are main factors associated with low viral reservoir in European perinatally HIV infected children, just accepted for publication in JAIDS, we demonstrate that HIV…
Read MoreODYSSEY: recruitment has completed!
29 Jun, 2018
We are pleased to announce that recruitment to the main trial has now completed. We have recruited slightly more than the total target of 700 participants: 312 recruited into ODYSSEY…
Read MoreItalian Medicines Agency: an important notice
25 Jun, 2018
We bring you an important notice from the Italian Medicines Agency concerning Darunavir and Cobicistat.
Read MoreEnrollment in the EARTH study within the EPIICAL project is moving fast
19 Jun, 2018
The EPIICAL Consortium is pleased to announce that enrollment in the EARTH study is moving fast. Two children have been recruited in Johannesburg Team (PHRU) led by Avy Violari, and…
Read MoreWHO and EMA statements on potential safety issue affecting women living with HIV using dolutegravir
01 Jun, 2018
Important information has been issued by the World Health Organization and the European Medicines Agency.
Read MoreEARTH: first patient has been recruited!
21 May, 2018
It is with great pleasure that we announce that the first patient in the EARTH study has been recruited. This encouraging news comes to us from the PHRU site in Soweto,…
Read MoreThe c4c project has been approved
21 May, 2018
We are delighted to announce the launch of the c4c project. This heralds a new public-private partnership to improve clinical trial infrastructure to facilitate the development of new drugs for…
Read MoreTr@inforPedHIV Guatemala: a big thanks to all participants
28 Apr, 2018
The 3-day course in Guatemala is over. Around 100 frontline healthcare professionals caring for HIV infected children from Guatemala, San Salvador, Ecuador, Panama, Mexico, Nicaragua and Costa Rica met in…
Read More10th annual International Workshop on HIV Pediatrics 2018 – Final call for abstract submission
27 Apr, 2018
The 10th annual International Workshop on HIV Pediatrics 2018 is fast approaching. Do not miss the opportunity to submit an abstract on your research.
Read More4th HIV Exposed Uninfected (HEU) child and adolescent workshop, Amsterdam – The Netherlands, July 22nd 2018
26 Apr, 2018
The International AIDS Society’s CIPHER initiative in partnership with WHO, UNICEF, PHACS and MassGeneral Hospital for Children will host the 4th HEU Child and Adolescent Workshop in Amsterdam, the Netherlands…
Read MoreODYSSEY B has completed recruitment with 395 children enrolled
12 Apr, 2018
ODYSSEY B, which compares dolutegravir versus standard-of-care drugs in HIV-infected children who are starting second-line treatment, has completed recruitment ahead of target.
Read MoreSMILE: enrollment has resumed
05 Apr, 2018
We are pleased to announce that enrollment in the SMILE study has recommenced. 3 new participants have recently been recruited in the clinical trial: 2 in Porto, Portugal and 1…
Read MoreCollaborating against HIV: Dr Sarah Watters podcast goes ‘viral’
28 Mar, 2018
Dr. Sarah Watters takes time out of her research to give us a fascinating peek into the world of viruses.
Read More